RSS Feed for Schizophrenia News From Medical News Today
Note: Content for this RSS feed is provided as a text alternative to inline RSS feeds that may not display on all browsers.
- Alkermes Unveils Long-Acting Injectable Proprietary Platform For Treatment Of Schizophrenia And Other CNS Disorders
published on Sun, 07 Feb 2010 00:00:00 PST
- Merz Pharma Announces Launch Of Denzapine As First Available Generic For Treatment-Resistant Schizophrenia
published on Sun, 07 Feb 2010 00:00:00 PST
- In Schizophrenia And Bipolar Disorder, Life Is Not Black And White
published on Fri, 05 Feb 2010 03:00:00 PST
- Fish Oil May Reduced Risk Of Psychotic Disorders In High Risk Individuals
published on Wed, 03 Feb 2010 07:00:00 PST
- The Prevention Of Psychiatric Patient Suicides
published on Wed, 03 Feb 2010 05:00:00 PST
- Identification Of Brain Protein For Synapse Development
published on Mon, 01 Feb 2010 02:00:00 PST
- Early Intervention Could Prevent Schizophrenia
published on Fri, 29 Jan 2010 05:00:00 PST
- Duke To Lead Effort To Better Understand The Role Of Rare Genetic Variation In Clozapine-induced Agranulocytosis Using Whole Genome Sequencing
published on Fri, 29 Jan 2010 00:00:00 PST
- The Hidden Cost Of Schizophrenia
published on Thu, 28 Jan 2010 05:00:00 PST
- Childhood Clues To Adult Schizophrenia
published on Sat, 23 Jan 2010 00:00:00 PST
- Blood Test For Schizophrenia Could Be Ready This Year
published on Fri, 22 Jan 2010 00:00:00 PST
- Launch Of Largest Academic-Industry Collaboration For Drug Discovery In Depression And Schizophrenia
published on Tue, 19 Jan 2010 02:00:00 PST
- A Flying Boost For Neuroscience
published on Sun, 17 Jan 2010 00:00:00 PST
- Examining The Impact Of FDA Safety Warnings
published on Tue, 12 Jan 2010 04:00:00 PST
- Race-Based Misdiagnosis Still Remains A Health Care Problem
published on Fri, 08 Jan 2010 00:00:00 PST
- Dainippon Sumitomo Pharma America Announces The NDA Submission Of Lurasidone To The FDA For The Treatment Of Schizophrenia
published on Wed, 06 Jan 2010 02:00:00 PST
- EnVivo Enters Phase 2b Trials For Its EVP-6124 Compound In The Treatment Of Schizophrenia
published on Wed, 06 Jan 2010 02:00:00 PST
- Before Or After Birth, Gene Linked To Mental Health Has Different Effects
published on Wed, 06 Jan 2010 00:00:00 PST
- Intra-Cellular Therapies Announces The Results Of A Phase I PET Study For ITI-007 For The Treatment Of Schizophrenia And Other Psychiatric Disorders
published on Tue, 22 Dec 2009 01:00:00 PST
- Alexza Announces Submission Of AZ-004 (Staccato(R) Loxapine) NDA
published on Wed, 16 Dec 2009 00:00:00 PST
- Workings Of Anti-Psychotic Drugs In The Living Brain Revealed By New Biosensors
published on Mon, 14 Dec 2009 03:00:00 PST
- Targacept Initiates Phase 2 Study Of TC-5619 In Cognitive Dysfunction In Schizophrenia
published on Sun, 13 Dec 2009 00:00:00 PST
- Late-Breaking Brain And Behavior Research Presented At ACNP Annual Meeting
published on Sat, 12 Dec 2009 00:00:00 PST
- Phase III Study Demonstrates INVEGA(R) SUSTENNA(TM) (paliperidone Palmitate) Statistically Similar To RISPERDAL(R) CONSTA(R) (risperidone)
published on Fri, 11 Dec 2009 03:00:00 PST
- FDA Approves Lilly's Zyprexa For Two Adolescent Indications
published on Sat, 05 Dec 2009 01:00:00 PST